Molecular Modeling Market Overview:

The molecular modeling market is expected to cross USD 1,617.80 million by 2027 at a CAGR of 15.93%. 

Molecular modeling refers to a technique used for drug designing. The global molecular modeling market has been witnessing enormous growth in recent times. The market's growth is being driven by the growing prevalence of chronic diseases, increasing investments in R&D by pharmaceutical and biotechnology companies, technological advancements in drug design, and the rise in drug development. However, the growth of the molecular modeling market is anticipated to be hampered by the lack of skilled healthcare professionals and the high cost of molecular modeling software.

Molecular Modeling Market Top Companies:

Simulations Plus, Inc (US)

Cambridge Crystallographic Data Centre (England)

Optibrium (UK)

Cresset (UK)

BioSolveIT GmbH (Germany)

OpenEye Scientific Software (US)

Chemical Computing Group (Canada)

Acellera Ltd (London)

Dassault Systèmes (France)

Schrödinger, LLC (US)

Certara, L.P (US)

Molecular Modeling Market Segmental Analysis:

The global market for molecular modeling is divided into several segments based on product, application, end-user, and region.

Based on product, the molecular modeling market is divided into software and services.

By application, the global market is bifurcated into drug discovery, drug development, and others.

The market is split into academic and research centers, biotechnology & pharmaceutical companies, and others based on end-user.

Molecular Modeling Market Regional Overview:

The global market for molecular modeling is divided into several regions, including the Americas, Asia-Pacific, Europe, and the Middle East &Africa.

The Americas regional market for molecular modeling is projected to secure the top position in the market globally. In 2020, the regional market will dominate globally with a maximum market share of over 40%. The dominance of the regional market is attributed to the growing adoption of products, prominent research institutes and academic organizations, and growing investments in the development of new techniques.

The Asia-Pacific regional molecular diagnostics products is likely to register the highest growth rate over the review timeframe from 2021 to 2027. The regional market performance is attributed to improving healthcare infrastructure, low production cost, an increasing number of contract research organizations, a growing number of research institutes, an increase in clinical trials, availability of a skilled workforce, and increasing disposable income.

The European regional market will contribute a share of over USD 173.29 million in 2020 and is projected to display a CAGR of over 15.70% during the assessment era. The market's growth is being driven by the increasing number of clinical trials and the rise in research funding.

The Middle East &African regional molecular modeling market is expected to show steady growth over the forecasted era. The regional market's growth is being propelled by the increasing online retailing for purchasing medicine and the gradual rise in the monetary status.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com